Arkolith/Insider Trading/CERO/Form 4

Fisher Douglas Carl

PresidentCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4 · filed Feb 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2024Other(J)43K——43K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Grant(A)50$1000.00$50K50
Feb 14, 2024Other(J)5K—$05K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-015029) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML